is bpc-157 banned by wada just added tirzepatide (mounjaro) to the 2026 Monitoring Program WADA publishes 2022 Prohibited List

Post-treatment elevation is interpreted differently from elevation without a clear exposure history

The safety profile appears favorable for extended use based on available data, though long-term studies specifically on oral formulations do not exist

Swirl lightly until the powder fully dissolves and the solution clears

However, limitations include in vivo instability, reliance on biocompatible and robust carriers and restricted application procedures (local and direct)

Conley CL, Krevans JR

The 15-amino-acid synthetic analogue used in research is stable in human gastric juice and does not require a carrier for in vitro work